[Circulatory effects of xanthinol nicotinate in advanced pregnancy (author's transl)].
Xanthinolnicotinate is a vasostimulant substance which is recommended to improve blood flow in the treatment of placental insufficiency. Quantitative sphygmometry with non-invasive graphic recording of arterial blood pressure was used in an attempt to study the effects of intravenous infusion of 300 mg of xanthinolnicotinate (Jupal) on the cardiovascular systems of ten women in advanced pregnancy with suspicion of intra-uterine foetal retardation. Their circulation remained basically unaffected, except for transient initial rise in pulse rate and cardiac output as well as decline of total peripheral resistance. However, additional blood supply to the skin and resulting shift in blood volumes may well provide a possibility of uteroplacental hypoperfusion, at least in cases in which perfusion had been restricted before. Administration of xanthinolnicotinate during pregnancy, therefore, cannot be recommended against the background of present knowledge.
D000328:Adult; D001775:Blood Circulation / Q000187:drug effects*; D001810:Blood Volume / Q000187:drug effects; D004341:Drug Evaluation; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D010922:Placenta Diseases / Q000188:drug therapy*; D010927:Placental Insufficiency / Q000188:drug therapy* / Q000503:physiopathology; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D013806:Theophylline / Q000031:analogs & derivatives*; D014971:Xanthinol Niacinate / Q000627:therapeutic use*
D014971:Xanthinol Niacinate; D013806:Theophylline
Kreislaufwirkungen von Xanthinolnikotinat in der Spätchwangerschaft.